Skip to content

Clinical trials

Phase 2/3 Head and Neck Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 2/3 Country / region: Germany Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated2
Active, not recruiting1
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bicara Therapeutics1
BioNTech SE1
Monopar Therapeutics1
Sanofi1
Sesen Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms5
Squamous Cell Carcinoma of Head and Neck3
Neoplasm Metastasis2
Camurati-Engelmann Syndrome1
Carcinoma, Squamous Cell1
Laryngeal Diseases1
Mouth Neoplasms1
Mucositis1
Neoplasm Recurrence, Local1
Neoplasms, Squamous Cell1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.